Design and analysis of cross-over trials, third edition

Design and Analysis of Cross-Over Trials, Third Edition

Volumn , Issue , 2014, Pages 1-404

  Jones, Byron ^a   Kenward, Michael G ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85052769790     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b17537     Document Type: Book

References (303)

1. Afsarinejad, K. (1983). Balanced repeated measurements designs. Biometrika, 70:199–204.
2. Afsarinejad, K. (1990). Repeated measurement designs — A review. Communication in Statistics — Theory and Methods, 19(11):3985–4028.
3. Afsarinejad, K. and Hedayat, A. S. (2002). Repeated measurements designs for a model with self and simple mixed carryover effects. Journal of Statistical Planning and Inference, 106:449–459.
4. Agresti, A. (1989). A survey of models for repeated ordered categorical response data. Statistics in Medicine, 8:1029–1224.
5. Agresti, A. and Lang, J. B. (1993). Quasi-symmetric latent class models, with application to rater agreement. Biometrics, 49:131–139.
6. Agresti, A., Lang, J. B., and Mehta, C. R. (1993). Some empirical comparisons of exact, modified exact, and higher-order asymptotic tests of independence for ordered categorical variables. Communications in Statistics, Simulation and Computation, 22:1–18.
7. Altan, S., McCartney, M., and Raghavarao, D. (1996). Two methods of analyses for a complex behavioural experiment. Journal of Biopharmaceutical Statistics, 4:437–447.
8. Altham, P. M. E. (1971). The analysis of matched proportions. Biometrika, 58:561–676.
9. Anderson, I. and Preece, D. A. (2002). Locally balanced change-over designs. Utilitas Mathematica, 62:33–59.
10. Ansersen, E. B. (1977). Sufficient statistics and latent trait models. Psychometrika, 42:69–81.
11. Archdeacon, D. S., Dinitz, J. H., Stinson, D. R., and Tillson, T. W. (1980). Some new row-complete Latin squares. Journal of Combinatorial Theory, Series A, 29:395–398.
12. Armitage, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics, 11:375–386.
13. Armitage, P. (1996). Design and analysis of clinical trials. In Gosh, S. and Rao, C. R., editors, Handbook of Statistics 13: Design and Analysis of Clinical Trials, pages 63–90. Elsevier Science B.V., Amsterdam.
14. Armitage, P. and Berry, G. (1987). Statistical Methods in Medical Research. Blackwell Scientific Publications: Oxford.
15. Atkinson, G. F. (1966). Designs for sequences of treatments with carry-over effects. Biometrics, 22:292–309.
16. Bailey, R. A. (1984). Quasi-complete Latin squares: construction and randomization. Journal of the Royal Statistical Society, Series B, 46:323–334.
17. 2 experimental units. Biometrics, 24:61–73.
18. Bate, S. T. and Jones, B. (2006). The construction of nearly balanced and nearly strongly balanced uniform cross-over designs. Journal of Statistical Planning and Inference, 136:3248–3267.
19. Bate, S. T. and Jones, B. (2008). A review of uniform cross-over designs. Journal of Statistical Planning and Inference, 138:336–351.
20. Bellavance, F., Tardif, S., and Stephens, M. A. (1996). Tests for the analysis of variance of crossover designs with correlated errors. Biometrics, 52:608– 612.
21. Berenblut, I. I. (1964). Change-over designs with complete balance for first residual effects. Biometrics, 20:707–712.
22. Berenblut, I. I. (1967a). A change-over design for testing a treatment factor at four equally spaced levels. Journal of the Royal Statistical Society, Series B, 29:370–373.
23. Berenblut, I. I. (1967b). The analysis of change-over designs with complete balance for first residual effects. Biometrics, 23:578–580.
24. Berenblut, I. I. (1968). Change-over designs balanced for the linear component of first residual effects. Biometrika, 55:297–303.
25. Birkett, M. A. and Day, S. J. (1994). Internal pilot studies for estimating sample size. Statistics in Medicine, 13:2455–2463.
26. Bishop, S. H. and Jones, B. (1984). A review of higher order crossover designs. Journal of Applied Statistics, 11(1):29–50.
27. Biswas, N. (1997). Some results on residual effects designs. PhD thesis, Temple University, Philadelphia, PA.
28. Biswas, N. and Raghavarao, D. (1998). Construction of rectangular and group divisible partially balanced residual effects designs by the method of differences. Journal of Combinatorics, Information and System Sciences, 23:135–141.
29. Blaisdell, E. A. (1978). Partially balanced residual effects designs. PhD thesis, Temple University, Philadelphia, PA.
30. Blaisdell, E. A. and Raghavarao, D. (1980). Partially balanced changeover designs based on m-associate class pbib designs. Journal of the Royal Statistical Society, Series B, 42:334–338.
31. Bornkamp, B., Bretz, F., and Pinhiero, J. (2014). R package: Dosefinding. CRAN.
32. Bornkamp, B., Pinheiro, J., and Bretz, F. (2009). MCPMod: An R package for the design and analysis of dose-finding studies. Journal of Statistical Software, 29:1–23.
33. Bose, M. and Dey, A. (2009). Optimal Crossover Designs. World Scientific, Singapore.
34. Bose, M. and Dey, A. (2013). Developments in crossover designs. http://www.isid.ac.in/statmath/2013/isid201307.pdf.
35. Bose, R. C. and Shimamoto, T. (1952). Classification and analysis of partially balanced incomplete block designs. Journal of the American Statistical Association, 47:151–184.
36. Box, G. E. P. (1954a). Some theorems on quadratic forms applied in the study of analysis of variance problems. Effect of inequality of variance in the one-way classification. Annals of Mathematical Statistics, 25:290–302.
37. Box, G. E. P. (1954b). Some theorems on quadratic forms applied in the study of analysis of variance problems. Effects of inequality of variance and of correlations between errors in the two way classification. Annals of Mathematical Statistics, 25:484–498.
38. Bradley, J. V. (1958). Complete counterbalancing of immediate sequential effects in a Latin square design. Journal of the American Statistical Association, 53:525–528.
39. Brandt, A. E. (1938). Tests of significance in reversal or switchback trials. Research Bulletin No. 234, Iowa Agricultural Experimental Station.
40. Breslow, N. E. and Day, N. E. (1980). Statistical Methods in Cancer Research – Volume 1. International Agency for Cancer Research: Lyon.
41. Bretz, F., Pinheiro, J. C., and Branson, M. (2005). Combining multiple comparisons and modelling techniques in dose-response studies. Biometrics, 61:738–748.
42. Carlin, B. P. and Louis, T. A. (1996). Bayes and Empirical Bayes Methods for Data Analysis. Chapman and Hall/CRC: New York.
43. Carpenter, J. R. and Kenward, M. G. (2008). Missing Data in Randomised Controlled Trials – A Practical Guide. UK NHS (NCCRM), Birmingham, UK.
44. Chassan, J. B. (1964). On the analysis of simple cross-overs with unequal numbers of replicates. Biometrics, 20:206–208.
45. Cheng, C. S. and Wu, C. F. (1980). Balanced repeated measurements designs. Annals of Statistics, 8:1272–1283, 11:349.
46. Ciminera, J. L. and Wolfe, R. K. (1953). An example of the use of extended cross-over designs in the comparison of NPH insulin mixtures. Biometrics, 9:431–446.
47. Clatworthy, W. H. (1973). Tables of two-associate partially balanced designs. National Bureau of Standards Applied Mathematics Series No. 63, U.S. Department of Commerce.
48. Cochran, W. G. (1939). Long-term agricultural experiments (with discussion). Journal of the Royal Statistical Society, Series B, 6:104–148.
49. Cochran, W. G., Autrey, K. M., and Cannon, C. Y. (1941). A double change-over design for dairy cattle feeding experiments. Journal of Dairy Science, 24:937–951.
50. Collombier, D. and Merchermek, I. (1993). Optimal cross-over experimental designs. Indian Journal of Statistics Series B, 55:161–249.
51. Conaway, M. R. (1989). Analysis of repeated categorical measurements with conditional likelihood methods. Journal of the American Statistical Association, 84:53–62.
52. Cook, R. D. and Weisberg, S. (1982). Residuals and Influence in Regression. Chapman and Hall: New York.
53. Cornell, R. G. (1980). Evaluation of bioavailability data using non-parametric statistics. In Albert, K. S., editor, Drug Absorption and Disposition: Statistical Considerations, pages 51–57. American Pharmaceutical Association.
54. Cornell, R. G. (1991). Nonparametric tests of dispersion for the two-period crossover design. Communications in Statistics, A, 20:1099–1106.
55. Cotter, S. C., John, J. A., and Smith, T. M. F. (1973). Multi-factor experiments in non-orthogonal designs. Journal of the Royal Statistical Society, Series B, 35:361–367.
56. Cotton, J. W. (1998). Analyzing Within-Subjects Experiments. Lawrence Erlbaum Associates: Mahwah, New Jersey.
57. Cox, D. R. (1972). Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B, 34:187–220.
58. Cox, D. R. (1984). Interaction. International Statistical Review, 52:1–31.
59. Cox, D. R. and Reid, N. (2000). The Theory of the Design of Experiments. Chapman and Hall/CRC: London.
60. Cox, D. R. and Snell, E. J. (1989). Analysis of Binary Data. Chapman and Hall: London.
61. Cramer, J. S. (1991). The Logit Model — An Introduction for Economists. Edward Arnold: London.
62. Crowder, M. (1995). On the use of a working correlation matrix in using generalised linear models for repeated measures. Biometrika, 82:407–410.
63. Cui, L., Hung, H. M. J., and Wang, S.-J. (1999). Modification of sample size in group sequential trials. Biometrics, 55:853–857.
64. Curtin, F. C., Elbourne, D., and Altman, D. G. (1995). Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes. Biometrika, 82:407–410.
65. Cytel (1995). StatXact 3 for Windows: Statistical Software for Exact Nonparametric Inference (User Manual). Cytel Software Corporation, Cambridge, MA.
66. Davis, A. W. and Hall, W. B. (1969). Cyclic change-over designs. Biometrika, 56(2):283–293.
67. Dean, A. M., Lewis, S. M., and Chang, J. Y. (1999). Nested changeover designs. Journal of Statistical Planning and Inference, 77(2):337–351.
68. DeMets, D. (2002). Clinical trials in the new millennium. Statistics in Medicine, 21:2779–2787.
69. Diggle, P. J., Heagerty, P., Liang, K. Y., and Zeger, S. L. (2002). Analysis of Longitudinal Data, Second Edition. Oxford University Press: Oxford.
70. Donev, A. N. (1997). An algorithm for the construction of crossover trials. Applied Statistics, 46(2):288–298.
71. Donev, A. N. and Jones, B. (1995). Construction of A-optimal designs. In Kitsos, C. P. and Mueller, W. G., editors, MODA4 — Advances in Model-Oriented Data Analysis, pages 165–171. Heidelberg, Physica-Verlag.
72. Dunsmore, I. R. (1981). Growth curves in two-period change-over models. Applied Statistics, 30:575–578.
73. Ebbutt, A. F. (1984). Three-period crossover designs for two treatments. Biometrics, 40:219–224.
74. Eccleston, J. and Street, D. (1994). An algorithm for the construction of optimal or near optimal change-over designs. Australian Journal of Statistics, 36(3):371–378.
75. Eccleston, J. and Whitaker, D. (1999). On the design of optimal change-over experiments through multi-objective simulated annealing. Statistics and Computing, 9(1):37–41.
76. EMA (2010). CHMP Guideline on the Investigation of Bioequivalence. European Medicines Agency.
77. EMA (2014). Draft Qualification Opinion of MCP-Mod as an efficient statistical methodology for model-based design and analysis of Phase II dose finding studies under model uncertainty. European Medicines Agency (EMA).
78. Farewell, V. T. (1985). Some remarks on the analysis of cross-over trials with a binary response. Applied Statistics, 34:121–128.
79. Fay, M. P. and Graubard, B. I. (2001). Small-sample adjustments for Wald-type tests using sandwich estimators. Biometrics, 57:1198–1206.
80. FDA (1992). FDA Guidance: Statistical procedures for bioequivalence studies using a standard two treatment cross-over design.
81. FDA (1997). FDA Draft Guidance: In vivo bioequivalence studies based on population and individual bioequivalence approaches.
82. FDA (1999a). FDA Draft Guidance: Average, population, and individual approaches to establishing bioequivalence.
83. FDA (1999b). FDA Draft Guidance: BA and BE studies for orally administered drug products: General considerations.
84. FDA (2000). FDA Guidance: Bioavailability and bioequivalence studies for orally administered drug products: General considerations.
85. FDA (2001). FDA Guidance: Statistical approaches to establishing bioequivalence.
86. FDA (2002). FDA Revised Guidance: Bioavailability and bioequivalence studies for orally administered drug products: General considerations.
87. FDA (2013). Draft Guidance on Loteprednol Etabonate. USA Food and Drug Administration.
88. Federer, W. T. (1955). Experimental Design – Theory and Application. Macmillan: New York.
89. Federer, W. T. and Atkinson, G. F. (1964). Tied-double-change-over designs. Biometrics, 20:168–181.
90. Fedorov, V. V., Jones, B., and Leonov, S. L. (2002). PK cross-over model with cost constraints. Presentation at Joint Statistical Meetings, New York, 2002.
91. Fieller, E. C. (1940). The biological standardization of insulin (with discussion). Supplement of the Journal of the Royal Statistical Society, 7:1–64.
92. Finney, D. J. (1956). Cross-over designs in bioassay. Proceedings of the Royal Society, Series B, 145:42–60.
93. Finney, D. J. and Outhwaite, A. D. (1955). Serially balanced sequences. Nature, 176:748.
94. Finney, D. J. and Outhwaite, A. D. (1956). Serially balanced sequences in bioassay. Proceedings of the Royal Society, Series B, 145:493–507.
95. Fisher, L. D. (1998). Self-designing clinical trials. Statistics in Medicine, 17:1551–1562.
96. Fleiss, J. L. (1986). On multiperiod crossover studies. Letter to the editor. Biometrics, 42:449–450.
97. Fletcher, D. and John, J. (1985). Changeover designs and factorial structure. Journal of the Royal Statistical Society, Series B, 47:117–124.
98. Fletcher, D. J. (1987). A new class of change-over designs for factorial experiments. Biometrika, 74:649–654.
99. Fluehler, H., Grieve, A. P., Mandallaz, D., Mau, J., and Moser, H. A. (1983). Bayesian approach to bioequivalence assessment: an example. Journal of Pharmaceutical Sciences, 72:1178–1181.
100. Ford, I., Norrie, J., and Ahmadi, S. (1995). Model inconsistency, illustrated by the Cox proportional hazards model. Statistics in Medicine, 14:735– 746.
101. France, L. A., Lewis, J. A., and Kay, R. (1991). The analysis of failure time data in crossover studies. Statistics in Medicine, 10:1099–1113.
102. Freeman, P. (1989). The performance of the two-stage analysis of two treatment, two period crossover trials. Statistics in Medicine, 8:1421–1432.
103. Friede, T. and Kieser, M. (2003). Blinded sample size reassessment in non-inferiority and equivalence trials. Statistics in Medicine, 22:995–1007.
104. Friedman, L. M., Furberg, C. D., and DeMets, D. L. (1998). Fundamentals of Clinical Trials (3rd edition). Springer-Verlag: Heidelberg.
105. Fuglsang, A. (2013). Sequential bioequivalence trial designs with increased power and control of type I error rates. The AAPS Journal, 15:659–661.
106. Fuglsang, A. (2014). Futility rules in bioequivalence trials with sequential designs. The AAPS Journal, 16:79–82.
107. Gail, M. H., Wineand, S., and Piantadosi, S. (1984). Biased estimates of treatment effect in randomized experiments with non linear regressions. Biometrika, 71:431–444.
108. Gamerman, D. and Lopes, H.F. (2006). Markov Chain Monte Carlo. Second Edition. Chapman and Hall/CRC: London.
109. Gart, J. J. (1969). An exact test for comparing matched proportions in crossover designs. Biometrika, 56:75–80.
110. Gelman, A., Carlin, J. B., Stern, H. S., and Rubin, D. B. (1995). Bayesian Data Analysis. Chapman and Hall/CRC: New York.
111. Gibbons, J. D. (1985). Nonparametric Statistical Inference. Marcel Dekker: New York.
112. Gilks, W. R., Richardson, S., and Spiegelhalter, D. J. (1996). Markov Chain Monte Carlo in Practice. Chapman and Hall/CRC: London.
113. Golkowski, D. (2011). Blinded sample size re-assessment in cross-over bioequivalence trials. Diploma Thesis in Mathematics, University of Heidelberg.
114. Golkowski, D., Friede, T., and Kieser, M. (2014). Blinded sample size reestimation in crossover bioequivalence trials. Pharmaceutical Statistics, 13:157–162.
115. Gould, A. L. (1995). Group sequential extensions of a standard bioequivalence testing procedure. Journal of Pharmacokinetics and Biopharmaceutics, 23:57–86.
116. Grieve, A. P. (1982). The two-period changeover design in clinical trials. Letter to the editor. Biometrics, 38:517.
117. Grieve, A. P. (1985). A Bayesian analysis of the two-period changeover design in clinical trials. Biometrics, 41:979–990.
118. Grieve, A. P. (1986). Corrigenda to Grieve (1985). Biometrics, 42:459.
119. Grieve, A. P. (1987). Application of Bayesian software: two examples. The Statistician, 36:282–288.
120. Grieve, A. P. (1990). Crossover vs parallel designs. In Berry, D. A., editor, Statistical Methodology in the Pharmaceutical Sciences, pages 239–270. Marcel Dekker: New York.
121. Grieve, A. P. (1994a). Bayesian analyses of two-treatment crossover studies. Statistical Methods in Medical Research, 3:407–429.
122. Grieve, A. P. (1994b). Extending a Bayesian analysis of the two-period crossover to allow for baseline measurements. Statistics in Medicine, 13:905–929.
123. Grizzle, J. E. (1965). The two-period change-over design and its use in clinical trials. Biometrics, 21:467–480.
124. Grizzle, J. E. (1974). Corrigenda to Grizzle (1965). Biometrics, 30:727.
125. Grizzle, J. E., Starmer, C. F., and Koch, G. G. (1969). Analysis of categorical data by linear models. Biometrics, 25:189–195.
126. Hauck, W. W., Hyslop, T. F., Anderson, S., Bois, F. Y., and Tozer, T. N. (1995). Statistical and regulatory considerations for multiple measures in bioequivalence testing. Clinical Research and Regulatory Affairs, 12:249–265.
127. Hauck, W. W., Preston, P. E., and Bois, P. E. (1997). A group sequential approach to crossover trials for average bioequivalence. Journal of Biopharmaceutical Statistics, 7:87–96.
128. Health Canada (2012). Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies. Health Canada.
129. Hedayat, A. S. and Afsarinejad, K. (1975). Repeated measurements designs. I. In Srivastava, J. N., editor, A Survey of Statistical Design and Linear Models, pages 229–242. North-Holland:Amsterdam.
130. Hedayat, A. S. and Afsarinejad, K. (1978). Repeated measurements designs, II. Annals of Statistics, 6:619–628.
131. Hedayat, A. S. Jacroux, M., and Majumdar, D. (1988). Optimal designs for comparing test treatments with controls. Statistical Science, 3:462–491.
132. Hedayat, A. S. and Zhao, W. (1990). Optimal two-period repeated measurements designs. Annals of Statistics, 18:1805–1816.
133. Hills, M. and Armitage, P. (1979). The two-period cross-over clinical trial. British Journal of Clinical Pharmacology, 8:7–20.
134. Ho, W.-K., Matthews, J. N. S., Henderson, R., Farewell, D. M., and Rogers, L. R. (2013). Two-period, two-treatment crossover designs subject to non-ignorable missing data. Statistics in Medicine, 31:1675–1687.
135. Hodges, J. L. and Lehman, E. L. (1963). Estimates of location based on rank tests. Annals of Mathematical Statistics, 34:598–611.
136. Hollander, M. and Wolfe, D. A. (1999). Nonparametric Statistical Methods. Wiley: New York.
137. Hunter, K. R., Stern, G. M., Lawrence, D. R., and Armitage, P. (1970). Amantadine in Parkinsonism. Lancet, i:1127–1129.
138. Iqbal, I. and Jones, B. (1994). Efficient repeated measurements designs with equal and unequal period sizes. Journal of Statistical Planning and Inference, 42(1-2):79–88.
139. Isaac, P. D., Dean, A. M., and Ostrum, A. (1999). Sequentially counterbalanced Latin squares. Technical Report No. 644. The Ohio State University, Columbus.
140. Jennison, C. and Turnbull, B. W. (2003). Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine, 22:971–993.
141. John, J. A. (1973). Generalized cyclic designs in factorial experiments. Biometrika, 60:55–63.
142. John, J. A. and Russell, K. G. (2002). A unified theory for the construction of crossover designs. Unpublished manuscript.
143. John, J. A. and Russell, K. G. (2003). Optimising changeover designs using the average efficiency factors. Journal of Statistical Planning and Inference, 113:259–268.
144. John, J. A. and Whitaker, D. (2002). CrossOver: An algorithm for the construction of efficient crossover designs. Unpublished manuscript.
145. John, P. W. (1971). Statistical Design and Analysis of Experiments. Macmillan: New York.
146. Jones, B. (1985). Using bricks to build block designs. Journal of the Royal Statistical Society, Series B, 47:349–356.
147. Jones, B. and Deppe, C. (2001). Recent developments in the design of cross-over trials: a brief review and bibliography. In Altan, S. and Singh, J., editors, Recent Advances in Experimental Designs and Related Topics, pages 153–173. Nova Science Publishers, Inc.: New York.
148. Jones, B. and Donev, A. N. (1996). Modelling and design of cross-over trials. Statistics in Medicine, 15:1435–1446.
149. Jones, B. and Kenward, M. G. (1989). Design and Analysis of Cross-over Trials. Chapman and Hall: London.
150. Jones, B., Kunert, J., and Wynn, H. P. (1992). Information matrices for mixed effects models with applications to the optimality of repeated measurements designs. Journal of Statistical Planning and Inference, 33:274–361.
151. Jones, B. and Wang, J. (1999). Constructing optimal designs for fitting pharmacokinetic models. Computing and Statistics, 9:209–218.
152. Jung, J. W. and Koch, G. G. (1999). Multivariate non-parametric methods for Mann-Whitney statistics to analyse cross-over studies with two treatment sequences. Statistics in Medicine, 18:989–1017.
153. Kalbfleish, J. D. and Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data. Wiley: Chichester.
154. Karalis, V. and Macheras, P. (2013). An insight into the properties of a two-stage design in bioequivalence studies. Pharmaceutical Research, 30:1824–1835.
155. Kauermann, G. and Carroll, R. J. (2001). A note on the efficiency of sandwich covariance estimation. Journal of the American Statistical Association, 96:1387–1396.
156. Kempthorne, O. (1983). The Design and Analysis of Experiments. Krieger: Malabar, Florida.
157. Kenward, M. G. (1987). A method for comparing profiles of repeated measurements. Applied Statistics, 36:296–308.
158. Kenward, M. G. and Jones, B. (1987). The analysis of data from 2×2 cross-over trials with baseline measurements. Statistics in Medicine, 6:911–926.
159. Kenward, M. G. and Jones, B. (1988). Crossover trials. In Kotz, S., Read, C. B., and Banks, D. L., editors, Encyclopedia of Statistical Sciences, Update Volume 2, pages 167–175. Wiley: New York.
160. Kenward, M. G. and Jones, B. (1991). The analysis of categorical data from cross-over trials using a latent variable model. Statistics in Medicine, 10:1607–1619.
161. Kenward, M. G. and Jones, B. (1992). Alternative approaches to the analysis of binary and categorical repeated measurements. Journal of Biopharmaceutical Statistics, 2:137–170.
162. Kenward, M. G. and Jones, B. (1994). The analysis of binary and categorical data from cross-over trials. Statistical Methods in Medical Research, 3:325– 344.
163. Kenward, M. G. and Roger, J. H. (1997). Small sample inference for fixed effects estimators from restricted maximum likelihood. Biometrics, 53:983– 997.
164. Kenward, M. G. and Roger, J. H. (2009). An improved approximation to the precision of fixed effects from restricted maximum likelihood. Computational Statistics and Data Analysis, 53:2583–2595.
165. Kenward, M. G. and Roger, J. H. (2010). The use of baseline covariates in cross-over studies. Biostatistics, 11:1–17.
166. Kenward, M. G., White, I. R., and Carpenter, J. R. (2010). Letter to the Editor on ‘Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?’ by Liu G.F. et al. (2009), Statistics in Medicine, 28, 2509–2530. Statistics in Medicine, 29:1455–1456.
167. Kershner, R. P. and Federer, W. T. (1981). Two-treatment crossover designs for estimating a variety of effects. Journal of the American Statistical Association, 76:612–618.
168. Kiefer, J. (1975). Construction and optimality of generalised Youden designs. In Srivastava, J. N., editor, A Survey of Statistical Design and Linear Models, pages 333–353. Amsterdam: North Holland.
169. Kieser, M. and Friede, T. (2003). Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Statistics in Medicine, 22:3571–3581.
170. Koch, G. G. (1972). The use of non-parametric methods in the statistical analysis of the two-period changeover design. Biometrics, 28:577–584.
171. Koch, G. G., Gitomer, S., Skalland, L., and Stokes, M. (1983). Some nonparametric and categorical data analysis for a changeover study and discussion of apparent carryover effects. Statistics in Medicine, 2:397–412.
172. Koch, G. G., Landis, J. R., Freeman, J. L., Freeman, D. H., and Lehnen, R. G. (1977). A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics, 33:133–158.
173. Kunert, J. (1983). Optimal designs and refinement of the linear model with applications to repeated measurements designs. Annals of Statistics, 11:247– 257.
174. Kunert, J. (1984). Optimality of balanced uniform repeated measurements designs. Annals of Statistics, 12:1006–1017.
175. Kunert, J. (1987). On variance estimation in cross-over designs. Biometrics, 43:833–845.
176. Kunert, J. (1991). Cross-over designs for two treatments and correlated errors. Biometrika, 78:315–324.
177. Kunert, J. and Stufken, J. (2002). Optimal crossover designs in a mixed model with self and mixed carryover effects. Journal of the American Statistical Association, 97:898–906.
178. Kushner, H. B. (1997a). Optimal repeated measurements designs: the linear optimality equations. Annals of Statistics, 25:2328–2344.
179. Kushner, H. B. (1997b). Optimality and efficiency of two treatment repeated measurements designs. Biometrika, 84:455–468.
180. Kushner, H. B. (1998). Optimal and efficient repeated measurement designs for uncorrelated observations. Journal of the American Statistical Association, 93(443):1176–1187.
181. Kushner, H. B. (1999). H-symmetric optimal repeated measurements designs. Journal of Statistical Planning and Inference, 76:235–261.
182. Labes, D. (2013). R package PowerTost: Power and sample size based on two one-sided t-tests (TOST) for (bio) equivalence studies, Version 1.1-06.
183. Lall, R., Campbell, M. D., Walters, S. J., and Morgan, K. (2002). A review of ordinal regression models applied on health-related quality of life assessment. Statistical Methods in Medical Research, 21:49–67.
184. Lancaster, H. O. (1961). Significance tests in discrete data. Journal of the American Statistical Association, 56:223–234.
185. Laska, E. M. and Meisner, M. (1985). A variational approach to optimal two-treatment crossover designs: applications to carry-over effect models. Journal of the American Statistical Association, 80:704–710.
186. Laska, E. M., Meisner, M., and Kushner, H. B. (1983). Optimal crossover designs in the presence of crossover effects. Biometrics, 39:1089–1091.
187. Lawes, J. B. and Gilbert, J. H. (1864). Report of experiments on the growth of wheat for twenty years in succession on the same land. Journal of the Agricultural Society of England, 25:93–185, 449–501.
188. Lehmacher, W. and Wassmer, G. (1999). Adaptive sample size calculations in group sequential designs. Biometrics, 55:1286–1290.
189. Lewis, S. M., Fletcher, D. J., and Matthews, J. N. S. (1988). Factorial crossover designs in clinical trials. In Dodge, Y., Fedorov, V. V., and Wynn, H. P., editors, Optimal Design and Analysis of Experiments, pages 133–140. North-Holland: Amsterdam.
190. Lewis, S. M. and Russell, K. G. (1998). Crossover designs in the presence of carry-over effects from two factors. Applied Statistics, 47(3):379–391.
191. Liang, K.-Y. and Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73:13–22.
192. Liang, K.-Y., Zeger, S. L., and Qaqish, B. (1992). Multivariate regression models for categorical data (with discussion). Journal of the Royal Statistical Society, Series B, 54:3–40.
193. Liebig, J. (1847). In Playfair, L. and Gregory, W., editors, Chemistry in its Application to Agriculture and Physiology (4th edition). In English. Taylor and Walton: London.
194. Lin, X. and Carroll, J. (2009). Non-parametric and semi-parametric regression methods for longitudinal data. In Fitzmaurice, G., Davidian, M., Verbeke, G., and Molenberghs, G., editors, Longitudinal Data Analysis, pages 199–222, Chapman & Hall/CRC Press: Boca Raton, FL.
195. Lindsey, J. K., Byrom, W. D., Wang, J., Jarvis, P., and Jones, B. (2000). Generalized nonlinear models for pharmacokinetic data. Biometrics, 56:30–36.
196. Linnerud, A. C., Gates, C. E., and Donker, J. D. (1962). Significance of carryover effects with extra period change-over design (abstract). Journal of Dairy Science, 45:675.
197. Lipsitz, S. R. and Fitzmaurice, G. M. (1994). Sample size for repeated measures studies with binary responses. Statistics in Medicine, 13:1233–1239.
198. Littell, R. C., Milliken, G. A., Stroup, W. W., and Wolfinger, R. D. (1996). SAS System for Mixed Models. SAS Institute Inc.: Cary, NC.
199. Longford, N. T. (1998). Count data and treatment heterogeneity in 2 × 2 crossover trials. Applied Statistics, 47:217–229.
200. Lucas, H. L. (1957). Extra-period Latin-square change-over designs. Journal of Dairy Science, 40:225–239.
201. Lund, R. E. (1975). Tables for an approximate test for outliers in linear models. Technometrics, 17:473–476.
202. Lunn, D., Jackson, C., Best, N., Thomas, A., and Spiegelhalter, D. (2013). The BUGS Book: A Practical Introduction to Bayesian Analysis. CRC Press: New York.
203. Mainland, D. (1963). Elementary Medical Statistics (2nd ed.). Saunders: Philadelphia.
204. Mancl, L. A. and DeRouen, T. A. (2001). A covariance estimator for GEE with improved small-sample properties. Biometrics, 57:126–134.
205. Mantel, N. (1963). Chi-square tests with one degree of freedom: Extension of Mantel-Haenszel procedure. Journal of the American Statistical Association, 58:690–700.
206. Marks, H. P. (1925). The biological assay of insulin preparations in comparison with a stable standard. British Medical Journal, 2:1102–1104.
207. Martin, R. J. and Eccleston, J. A. (1998). Variance-balanced change-over designs for dependent observations. Biometrika, 85(4):883–892.
208. Matthews, J. N. S. (1987). Optimal crossover designs for the comparison of two treatments in the presence of carryover effects and autocorrelated errors. Biometrika, 74:311–320.
209. Matthews, J. N. S. (1988). Recent developments in crossover designs. International Statistical Review, 56:117–127.
210. Matthews, J. N. S. (1990). Optimal dual-balanced two treatment crossover designs. Sankhya Ser. B, 52:332–337.
211. Matthews, J. N. S. (1994a). Modelling and optimality in the design of crossover studies for medical applications. Journal of Statistical Planning and Inference, 42:89–108.
212. Matthews, J. N. S. (1994b). Multiperiod crossover designs. Statistical Methods in Medical Research, 3:383–405.
213. Matthews, J. N. S. and Henderson, R. (2013). Two-period, two-treatment crossover designs subject to non-ignorable missing data. Biostatistics, 14:626–638.
214. Matthews, J. N. S., Henderson, R., Farewell, D. M., Ho, W.-K., and Rogers, L. R. (2013). Dropout in crossover and longitudinal studies: Is complete case so bad? Statistical Methods in Medical Research, 23:60–73.
215. McCullagh, P. (1980). Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, Series B, 42:109–142.
216. McCullagh, P. and Nelder, J. A. (1989). Generalized Linear Models, Second Edition. Chapman and Hall: London.
217. McNemar, Q. (1947). Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika, 12:153–157.
218. McNulty, P. A. (1986). Spatial Velocity Induction and Reference Mark Density. PhD thesis, University of California, Santa Barbara, CA.
219. Millard, S. and Krause, A. (2001). Applied Statistics in the Pharmaceutical Industry with Case Studies using S-Plus. Springer-Verlag: New York.
220. Molenberghs, G. and Kenward, M. G. (2007). Missing Data in Clinical Studies. Wiley: Chichester.
221. Molenberghs, G. and Verbeke, G. (2000). Models for Distrete Longitudinal Data. Springer Verlag: New York.
222. Molenberghs, G., Verbeke, G., Demétrio, C., and Vieira, A. (2010). A family of generalized linear models for repeated measures with normal and conjugate random effects. Statistical Science, 25:325–347.
223. Montague, T. H., Potvin, D., DiLiberti, C. E., Hauck, W. W., Parr, A. F., and Schuirmann, D. J. (2012). Additional results for ‘Sequential design appraoches for bioequivalence studies with crossover designs’. Pharmaceutical Statistics, 11:8–13.
224. Nam, J. (1971). On two tests for comparing matched proportions. Biometrics, 27:945–959.
225. Namboordiri, K. N. (1972). Experimental design in which each subject is used repeatedly. Psychological Bulletin, 77:54–64.
226. Newcombe, R. G. (1996). Sequentially balanced three-squares cross-over designs. Statistics in Medicine, 15:2143–2147.
227. Newhaus, J. M., Kalbfleisch, J. D., and Hauck, W. W. (1991). A comparison of cluster-specific and population-averaged approaches for analyzing correlated binary data. International Statistical Review, 59:25–35.
228. Oakes, D. (1986). Semiparametric inference, in a model for association in bivariate survival data. Biometrika, 73:353–361.
229. Pan, W. and Wall, M. (2002). Small-sample adjustments in using the sandwich variance estimator in generalized estimating equations. Statistics in Medicine, 21:1429–1441.
230. Parkes, K. R. (1982). Occupational stress among student nurses. Journal of Applied Psychology, 67:784–796.
231. Patel, H. I. (1983). Use of baseline measurements in the two period cross-over design. Communications in Statistics — Theory and Methods, 12:2693– 2712.
232. Patterson, H. D. (1950). The analysis of change-over trials. Journal of Agricultural Science, 40:375–380.
233. Patterson, H. D. (1951). Change-over trials. Journal of the Royal Statistical Society, Series B, 13:256–271.
234. Patterson, H. D. (1952). The construction of balanced designs for experiments involving sequences of treatments. Biometrika, 39:32–48.
235. Patterson, H. D. (1970). Non-additivity in change-over designs for a quantitative factor at four levels. Biometrika, 57:537–549.
236. Patterson, H. D. (1973). Quenouille’s change-over designs. Biometrika, 60:33– 45.
237. Patterson, H. D. and Lucas, H. L. (1962). Change-over designs. North Carolina Agricultural Experimental Station, Tech. Bull. No. 147.
238. Patterson, S. D. and Jones, B. (2006). Bioequivalence and Statistics in Clinical Pharmacology. Chapman and Hall/CRC Press: Boca Raton.
239. Pepe, M. S. and Anderson, G. L. (1994). A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Communications in Statistics — Simulation and Computation, 23:939–951.
240. Peterson, B. and Harrell, F. E. (1990). Partial proportional odds models for ordinal response variables. Journal of the Royal Statistical Society, Series A, 39:205–217.
241. Pigeon, J. G. (1984). Residual effects designs for comparing treatments with a control. PhD dissertation. Temple University, Philadelphia, PA.
242. Pigeon, J. G. and Raghavarao, D. (1987). Crossover designs for comparing treatments with a control. Biometrika, 74:321–328.
243. Pinheiro, J., Bornkamp, B., Glimm, E., and Bretz, F. (2014). Multiple comparisons and modelling for dose finding using general parametric models. Statistics in Medicine, 33:1646–1661.
244. Pocock, S. J. (1983). Clinical Trials. Wiley: Chichester.
245. Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika, 64:191–199.
246. Pocock, S. J., Assmann, S. E., Enos, L. E., and Kasten, L. E. (2002). Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: curent practice and problems. Statistics in Medicine, 21:2917– 2930.
247. Potvin, D., DiLiberti, C. E., Hauck, W. W., Parr, A. F., Schuirmann, D. J., and Smith, R. A. (2008). Sequential design approaches for bioequivalence studies with crossover designs. Pharmaceutical Statistics, 7:245–262.
248. Prescott, P. (1999). Construction of sequentially counterbalanced designs formed from two Latin squares. Utilitas Mathematica, 55:135–152.
249. Prescott, R. J. (1979). On McNemar’s and Gart’s tests for cross-over trials. Letter to the editor. Biometrics, 35:523–524.
250. Prescott, R. J. (1981). The comparison of success rates in cross-over trials in the presence of an order effect. Applied Statistics, 30:9–15.
251. Proschan, M., Lan, K. K. G., and Wittes, J. T. (2006). Statistical Monitoring of Clinical Trials. Springer: New York.
252. Quenouille, M. H. (1953). The Design and Analysis of Experiments. Griffin: London.
253. Racine, A., Grieve, A. P., Fluehler, H., and Smith, A. F. M. (1986). Bayesian methods in practice: Experiences in the pharmaceutical industry (with discussion). Applied Statistics, 35:93–150.
254. Raghavarao, D. (1971). Constructions and Combinatorial Problems in Design of Experiments. Wiley: New York.
255. Raghavarao, D. (1989). Crossover designs in industry. In Gosh, S., editor, Design and Analysis of Experiments, with Applications to Engineering and Physical Sciences. Marcel Dekker: New York.
256. Raghavarao, D. and Xie, Y. (2003). Split-plot type residual effects designs. JSPI, 116:197–207.
257. Rohmeyer, K. (2014). R package: Crossover. CRAN.
258. Rohmeyer, K. and Janes, B. (2015). Examples of using the R package Crossover, In preparation.
259. Rosenkranz, G. K. (2014). Analysis of cross-over studies with missing data. Statistical Methods in Medical Research, 24:000–000.
260. Rowland, M. and Tozer, T. N. (1995). Clinical Pharmacokinetics Concepts and Applications, Third Edition. Lippincott, Williams and Wilkins: Philadelphia.
261. Ruppert, D., Wand, M. P., and Carroll, R. J. (2003). Semiparametric Regression. Cambridge University Press: Cambridge.
262. Russell, K. G. (1991). The construction of good change-over designs when there are fewer units than treatments. Biometrika, 78:305–313.
263. Russell, K. G. and Dean, A. M. (1998). Factorial designs with few subjects. Journal of Combinatorics, Information and System Sciences, 23:209–235.
264. Sampford, M. R. (1957). Methods of construction and analysis of serially balanced sequences. Journal of the Royal Statistical Society, Series B, 19:286– 304.
265. SAS (2014). SAS/STAT User’s Guide, Version 9.3. SAS Insitute Inc: Cary, NC.
266. Satterthwaite, F. E. (1946). An approximate distribution of estimates of variance components. Biometrics Bulletin, 2:110–114.
267. Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15:657–680.
268. Seath, D. M. (1944). A 2 × 2 factorial design for double reversal feeding experiments. Journal of Dairy Science, 27:159–164.
269. Selwyn, M. R., Dempster, A. R., and Hall, N. R. (1981). A Bayesian approach to bioequivalence for the 2 × 2 changeover design. Biometrics, 37:11–21.
270. Sen, M. and Mukerjee, R. (1987). Optimal repeated measurement designs under interaction. Journal of Statistical Planning and Inference, 17:81–91.
271. Senn, S. J. (1993). Cross-over Trials in Clinical Research. Wiley: Chichester.
272. Senn, S. J. (1996). The AB/BA cross-over: How to perform the two-stage analysis if you can’t be persuaded that you shouldn’t. In Hansen, B. and de Ridder, M., editors, Liber Amicorum Roel van Strik, pages 93–100. Erasmus University: Rotterdam.
273. Senn, S. J. (1997a). Cross-over trials. In Armitage, P. and Colton, T., editors, Encyclopedia in Biostatistics, 2, pages 1033–1049. Wiley: New York.
274. Senn, S. J. (1997b). The case for cross-over trials in Phase III. Letter to the Editor. Statistics in Medicine, 16:2021–2022.
275. Senn, S. J. (2000). Crossover design. In Chow, S. C., editor, Encyclopedia of Biopharmaceutical Statistics, pages 142–149. Marcel Dekker: New York.
276. Senn, S. J. (2002). Cross-over Trials in Clinical Research. Second Edition. Wiley: Chichester.
277. Sharples, K. and Breslow, N. (1992). Regression analysis of binary data: Some small sample results for the estimating equation approach. Journal of Statistical Computation and Simulation, 42:1–20.
278. Sheehe, P. R. and Bross, I. D. J. (1961). Latin squares to balance immediate residual and other effects. Biometrics, 17:405–414.
279. Sheppard, L. (2003). Insights on bias and information in group-level studies. Biostatistics, 4:265–278.
280. Simpson, T. W. (1938). Experimental methods and human nutrition (with discussion). Journal of the Royal Statistical Society, Series B, 5:46–69.
281. Skene, S. and Kenward, M. G. (2010a). The analysis of very small samples of repeated masaurements. II. A modified Box correction. Statistics in Medicine, 29:2838–2856.
282. Skene, S. and Kenward, M. G. (2010b). The analysis of very small samples of repeated measurements. I. An adjusted sandwich estimator. Statistics in Medicine, 29:2825–2837.
283. Spiegelhalter, D., Thomas, N., and Best, N. (2000). WinBUGS. Version 1.3 User Manual. MRC Biostatistics Unit, Cambridge, UK.
284. Stokes, M. S., Davis, C. S., and Koch, G. G. (2012). Categorical Data Analysis Using the SAS System, 3rd Edition. SAS Institute Inc.: Cary, NC.
285. Struthers, C. A. and Kalbfleisch, J. D. (1986). Misspecified proportional hazards models. Biometrika, 73:363–369.
286. Stufken, J. (1991). Some families of optimal and efficient repeated measurement designs. Journal of Statistical Planning and Inference, 27:75–83.
287. Stufken, J. (1996). Optimal crossover designs. In Gosh, S. and Rao, C. R., editors, Handbook of Statistics 13: Design and Analysis of Experiments, pages 63–90. North Holland: Amsterdam.
288. Tudor, G. E. and Koch, G. G. (1994). Review of nonparametric methods for the analysis of crossover studies. Statistical Methods in Medical Research, 3:345–381.
289. Tudor, G. E., Koch, G. G., and Catellier, D. (2000). Statistical methods for crossover designs in bioenvironmental and public health studies. In Sen, P. K. and Rao, C. R., editors, Handbook of Statistics, Vol 18, pages 571– 614. Elsevier Science B.V., Amsterdam.
290. Vartak, M. N. (1955). Review of nonparametric methods for the analysis of crossover studies. Annals of Mathematical Statistics, 26:420– 438.
291. Verbeke, G. and Molenberghs, G. (2000). Linear Mixed Models for Longitudinal Data. Springer Verlag: New York.
292. Wallenstein, S. (1979). Inclusion of baseline values in the analysis of crossover designs (abstract). Biometrics, 35:894.
293. Welham, S. J. (2009). Smoothing spline models for longitudinal data. In Fitzmaurice, G., Davidian, M., Verbeke, G., and Molenberghs, G., editors, Longitudinal Data Analysis, pages 253–290. Chapman & Hall/CRC Press: Boca Raton, FL.
294. Welling, P. G. (1986). Pharmacokinetics: Processes and Mathematics. American Chemical Society.
295. White, H. (1982). Maximum likelihood estimation of misspecified models. Econometrika, 50:1–25.
296. Willan, A. R. and Pater, J. L. (1986). Using baseline measurements in the two-period crossover clinical. Controlled Clinical Trials, 7:282–289.
297. Williams, E. J. (1949). Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Research, 2:149–168.
298. Williams, E. J. (1950). Experimental designs balanced for pairs of residual effects. Australian Journal of Scientific Research, 3:351–363.
299. Yates, F. (1938). The gain in efficiency resulting from the use of balanced designs. Journal of the Royal Statistical Society, Series B, 5:70–74.
300. Zeger, S. L. (1988). Commentary on papers on the analysis of repeated categorical response. Statistics in Medicine, 7:161–168.
301. Zeger, S. L. and Liang, K.-Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42:121–130.
302. Zeger, S. L., Liang, K. Y., and Albert, P. S. (1988). Models for longitudinal data: a generalized estimating equation approach. Biometrics, 44:1049–1060.
303. Zucker, D. M., Wittes, J. T., Schabenberger, O., and Brittain, E. (1999). Internal pilot studies. II. Comparison of various procedures. Statistics in Medicine, 18:3493–3509.